Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer

ClinicalTrials.gov ID: NCT00567190

Public ClinicalTrials.gov record NCT00567190. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 7:00 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study was a Phase III, randomized, double-blind, placebo-controlled, multicenter international clinical trial conducted to investigate the use of pertuzumab in combination with trastuzumab and docetaxel as first-line treatment for participants with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC). Participants could have received one prior hormonal treatment for MBC. Participants may have received systemic breast cancer treatment in the neo-adjuvant or adjuvant setting, provided that the participant had experienced a disease-free interval (DFI) of greater than or equal to (≥)12 months from completion of adjuvant systemic treatment (excluding hormonal therapy) to metastatic diagnosis. Participants may have received trastuzumab and/or a taxane during the neo-adjuvant or adjuvant treatment. Participants were randomized in 1:1 ratio to receive either pertuzumab or placebo, along with trastuzumab and docetaxel once every 3 weeks (q3w), during the treatment phase of the study until investigator-assessed radiographic or clinical progressive disease, unmanageable toxicity, or study termination. Participants in the Placebo arm were not allowed to receive open-label pertuzumab after discontinuation from study treatment. However, if any analysis of overall survival had met the predefined criteria for statistical significance, participants in the Placebo arm still on treatment were offered the option to receive open-label pertuzumab in addition to other study medications.

Study identification

NCT ID
NCT00567190
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Genentech, Inc.
Industry
Enrollment
808 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 12, 2008 (Actual)
Primary completion
May 13, 2011 (Actual)
Completion
Nov 23, 2018 (Actual)
Last update posted
Dec 13, 2019

2008 – 2018

United States locations

U.S. sites
159
U.S. states
34
U.S. cities
123
Facility City State ZIP Site status
HonorHealth Research Institute - Bisgrove Scottsdale Arizona 85258 —
NEA Baptist Clinic Jonesboro Arkansas 72401 —
Central Hematology Oncology Medical Group Inc. Alhambra California 91801 —
Pacific Cancer Medical Center Anaheim California 92801 —
Comprehensive Blood/Cancer Ctr Bakersfield California 93309 —
Kaiser Permanente - Baldwin Park Baldwin Park California 91706 —
Tower Cancer Research Foundation Beverly Hills California 90211 —
South Bay Oncology Hematology Partners Campbell California 95008 —
Wilshire Oncology Medical Group Corona California 92879 —
Compassionate Cancer Care Fountain Valley California 92708 —
Pacific Coast Hematology/Oncology Medical Group Fountain Valley California 92708 —
St. Jude Heritage Healthcare; Virgiia K.Crosson Can Ctr Fullerton California 92835 —
Wilshire Onc Med Grp., Inc Glendora California 91741 —
Wilshire Oncology Medical Group La Verne California 91750 —
UCLA Los Angeles California 90024 —
LAC USC Medical Center Los Angeles California 90033 —
Cedars- Sinai Medical Center Los Angeles California 90048 —
Ronald Reagan UCLA Medical Center Clin Lab Los Angeles California 90095 —
TORI Central Administration Los Angeles California 90095 —
UCLA Hematology / Oncology Clinic Los Angeles California 90095 —
UCLA Med Ctr; Pharma Svcs Los Angeles California 90095 —
Sutter Gould Medical Foundation; Clinical Research Modesto California 95355 —
Kaiser Permanente - Oakland Oakland California 94611 —
Ventura County Hematology-Oncology Specialists Oxnard California 93030 —
UCLA Healthcare/Pasadena Oncology Pasadena California 91105 —
Wilshire Oncology Medical Group Pasadena California 91750 —
Bay Area Cancer Research Group, LLC Pleasant Hill California 94523 —
Wilshire Oncology Medical Group Pomona California 91767 —
Wilshire Oncology Medical Group Rancho Cucamonga California 91730 —
UC Davis Cancer Center; Oncology Sacramento California 95817 —
Kaiser Permanente San Diego; Hepatology Research San Diego California 92154 —
K. Permanente - San Fransisco San Francisco California 94115 —
K. Permanente - San Jose San Jose California 95119 —
Sansum Santa Barbara Medical Foundation Clinic Santa Barbara California 93105 —
Santa Barbara Hematology Oncology Medical Group, Inc. Santa Barbara California 93105 —
UCLA Hematology/Oncology Santa Monica California 90404 —
UCLA / Santa Clarita Valley Cancer Center Valencia California 91355 —
Kaiser Permanente - Vallejo Vallejo California 94589 —
K. Permanente - Walnut Creek Walnut Creek California 94596 —
Wilshire Oncology Medical Group West Covina California 91790 —
Innovative clinical research institute/American institute of research Whittier California 90603 —
Georgetown University Medical Center Lombardi Cancer Center Washington D.C. District of Columbia 20007 —
MedStar Washington Hosp Center Washington D.C. District of Columbia 20010 —
Sibley Memorial Hospital Washington D.C. District of Columbia 20016 —
Boca Raton Comprehensive Cancer Center Boca Raton Florida 33428 —
Florida Cancer Specialists -Cape Coral (Cape Coral Pkwy) Cape Coral Florida 33914 —
Florida Cancer Specialists - Cape Coral (Del Prado Blvd) Cape Coral Florida 33990 —
Northwest Oncology/ Hematology Assoc. Coral Springs Florida 33065-5701 —
UM Sylvester Deerfield Beach; Sylvester Cancer Ctr Deerfield Beach Florida 33442 —
Florida Cancer Specialists - Englewood Englewood Florida 34223 —
Florida Cancer Specialists - Fort Myers (New Hampshire Ct) Fort Myers Florida 33901-8101 —
Florida Cancer Specialists - Broadway Fort Myers Florida 33901 —
Florida Cancer Specialists; SCRI Fort Myers Florida 33901 —
Florida Cancer Specialists-Broadway, Fort Myers Fort Myers Florida 33908 —
Private Practice Robert R. Carroll, Md, Pa Gainesville Florida 32605 —
Memorial Cancer Institute Hollywood Florida 33021 —
Memorial Regional Hospital Hollywood Florida 33021 —
Lakeland Regional Cancer Center Lakeland Florida 33804-1057 —
Jackson Memorial Hospital Miami Florida 33136 —
University of Miami School of Medicine Miami Florida 33136 —
Florida Cancer Specialists - Goodlette, Naples Naples Florida 34102 —
Florida Cancer Specialists - Pine Ridge, Naples Naples Florida 34119 —
Private Practice Orlando Florida 32804 —
Breast Cancer Centre at Memorial Hospital West Pembroke Pines Florida 33028 —
Florida Cancer Specialists - Port Charlotte Port Charlotte Florida 33980 —
Florida Cancer Specialists; Sarasota Sarasota Florida 34232 —
Bay Area Oncology Tampa Florida 33607 —
Florida Cancer Specialists - Venice (S. Tamiami Tr) Venice Florida 33980 —
Florida Cancer Specialists - Sunset Lake, Venice Venice Florida 34292 —
Cleveland Clinic Florida Weston Florida 33331 —
Northeast Georgia Medical Center; Oncology Research Dept-5C Gainesville Georgia 30501 —
Central Georgia Hematology Oncology Associates Macon Georgia 31201 —
Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital Marietta Georgia 30060 —
Central GA Cancer Care Warner Robins Georgia 31088-2259 —
Elmhurst Hospital Elmhurst Illinois 60126 —
Hematology Oncology Consultants Ltd Naperville Illinois 60540 —
Quincy Medical Group Quincy Illinois 62301 —
Midwestern Regional Medical Center; Office of Research Zion Illinois 60099 —
Monroe Medical Associates - Hobart Hobart Indiana 46342 —
St. Mary Medical Center Hobart Indiana 46432 —
Hematology-Oncology of Indiana, Pc Indianapolis Indiana 46260 —
Community Hospital; Pharmacy Munster Indiana 46321 —
Northwest Oncology Munster Indiana 46321 —
Monroe Medical Associates Munster Indiana 46375 —
Family Medicine Vincennes Vincennes Indiana 47591 —
Uni of Iowa Hospital&Clinic; Holden Comprehens. Cancer Ctr Iowa City Iowa 52242 —
University of Kansas; Medical Center & Medical pavilion Westwood Kansas 66205 —
Cancer Center of Kansas Wichita Kansas 67214-3728 —
Jewish Cancer Care Louisville Kentucky 40245 —
Cancer Center of Acadiana at Lafayette General Lafayette Louisiana 70506 —
Christus Schumpert Health System Shreveport Louisiana 71101-1978 —
Private Practice- Carolyn Hendricks, MD Bethesda Maryland 20817 —
Boston Medical Center Boston Massachusetts 02118-2393 —
Berkshire Hematology, Oncology Pc Pittsfield Massachusetts 01201 —
Cancer & Hematology Centers of Western Michigan Grand Rapids Michigan 49503 —
Cancer & Hematology Center of West Michigan Grand Rapids Michigan 49546 —
Oncology Care Associates PLLC Saint Joseph Michigan 49085 —
Southdale Cancer Clinic U of M Medical Center, Fairview- Edina Edina Minnesota 55435 —
US Oncology Research at Minnesota Oncology Minneapolis Minnesota 55404 —
Minneapolis Oncology Hamatology PA Minneapolis Minnesota 55407-3799 —
The Jones Clinic, PC New Albany Mississippi 38652 —
St. Vincent Frontier Cancer Center Billings Montana 59101 —
Southeast Nebraska Cancer Center;; Southeast Nebraska Hematology and Oncology Lincoln Nebraska 68510 —
Norfolk Oncology Consultants Norfolk Nebraska 68701 —
Hematology-Oncology Consultants, Pc Omaha Nebraska 68122 —
Southern Nevada Cancer Research Foundation Las Vegas Nevada 89106 —
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756 —
St. Barnabas Cancer Center Livingston New Jersey 07039 —
Oncology and Hematology Specialists Mountain Lakes New Jersey 07046 —
San Juan Oncology Associates Farmington New Mexico 87401 —
Brockport-Interlakes Foundation Brockport New York 14420 —
Canandaigua-Interlakes Found Canandaigua New York 14420 —
Geneva-Interlakes Foundation Geneva New York 14456 —
ProHEALTH Care Associates LLP Lake Success New York 11042 —
Beth Israel Comprehensive Cancer Center Pharmacy New York New York 10011 —
The Women'sOncology & Wellness Practice New York New York 10016 —
Upstate Ny Cancer Research & Education Foundation Rochester New York 14623 —
Duke University Medical Center Durham North Carolina 27710 —
Carolina Oncology Specialists, PA - Hickory Hickory North Carolina 28602 —
Carolina BioOncology Institute, PLCC Huntersville North Carolina 28078 —
NW Carolina Onc & Hem Lenoir North Carolina 28645 —
Gabrail Cancer Center Canton Ohio 44718 —
Oncology Hematology Care Inc Cincinnati Ohio 45242 —
Hema Onc Conslts-Grant Ave Columbus Ohio 43215 —
The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc. Columbus Ohio 43219 —
Hematology Onc Consultants Columbus Ohio 43228 —
Gabrail Cancer Center Dover Ohio 44622 —
Hematology Oncology Consultants (NWK) Granville Ohio 43023 —
Medical College of Ohio; Cancer Institute Toledo Ohio 43614 —
Mercy Physicians of Oklahoma Oklahoma City Oklahoma 73120 —
CA Care Associates-OK Oncology and Hematology Tulsa Oklahoma 74104 —
Cancer Care Assoc-S. Ingo Tulsa Oklahoma 74133 —
OK Oncology & Hematology PC Tulsa Oklahoma 74136 —
Cons in Med Onc and Hem Darby Pennsylvania 19026 —
Consultants in Medical Oncology/Hematology Drexel Hill Pennsylvania 19026 —
Armstrong County Memorial Hospital Kittanning Pennsylvania 16201 —
Conslts in Med Onc (Newtown); Bryn Mawr Health Canc Ctr Newtown Square Pennsylvania 19073 —
Uni of Pittsburgh; Magee-Women'S Hospital Pittsburgh Pennsylvania 15213 —
Consultants Med Onc & Hem Ridley Park Pennsylvania 19078 —
Erlanger Health System; Oncology Research Chattanooga Tennessee 37403 —
SCRI Tennessee Oncology Chattanooga Chattanooga Tennessee 37404 —
McLeod Cancer and Blood Center Johnson City Tennessee 37604 —
University of Tennessee Cancer Institute;Hem-Onc Consultants Knoxville Tennessee 37920 —
Sarah Cannon Cancer Center - Tennessee Oncology, Pllc Nashville Tennessee 37203 —
Park Plaza Houston Texas 77004 —
Southwest Houston Texas 77008 —
St. Joseph's Houston Texas 77008 —
Memorial City-Main Office Houston Texas 77024 —
Oncology Consultants Houston Texas 77024 —
St. Luke's Houston Texas 77030 —
Willowbrook Houston Texas 77070 —
Katy-Christus St. Catherine Katy Texas 77450 —
South Texas Oncology Hematology San Antonio Texas 78258 —
Oncology Consultants - Sugar Land Sugar Land Texas 77479 —
Northern Utah Associates Ogden Utah 84403 —
Community Cancer Center Rutland Regional Medical Center Rutland Vermont 05701 —
Wellmonth Physician Services Bristol Virginia 24201 —
Northwest Medical Specialties Tacoma Washington 98405 —
St. Mary Medical Center Walla Walla Washington 99362 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 163 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00567190, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 13, 2019 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00567190 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →